Cannabis Clinical Trials

Recognition of the potential therapeutic benefits of medicinal cannabis for a range of debilitating health conditions has been growing for several years. Recent legislative amendments open the door for the cultivation and production of medicinal cannabis products on Australian soil for the first time. This update provides an overview of the current framework regulating patient […]

The backbone of medical advancement is biotechnology, an industry wrought with the incredible potential of novel drug RD, but vulnerable to the risk of stringent regulatory approval processes. Within this volatile market, however, is the cannabis-biotech sub-sector – a market flourishing with opportunity, innovation, and deep roots of medical possibilities. Fueled by an increasing volume […]

Roberto and Maria’s 13-year-old daughter has Dravet syndrome which causes many severe seizures daily. But with the help of a cannabis compound, she’s been nearly seizure free.  It’s bed time for 13-year-old Viridiana. And as her parents, Roberto and Maria, read to her, they know their daughter’s own story is different than a normal child’s. […]

Roberto and Maria’s 13-year-old daughter has Dravet syndrome which causes many severe seizures daily. But with the help of a cannabis compound, she’s been nearly seizure free.  It’s bed time for 13-year-old Viridiana. And as her parents, Roberto and Maria, read to her, they know their daughter’s own story is different than a normal child’s. […]

When medical cannabis laws made their debut in the latter half of the 1990s, they were intended to protect cancer patients from prosecution. These patients found a medication that combatted the harsh, nauseating side effects of chemotherapy, and though cannabis’ efficacy was largely anecdotal at the time, we can now look at the science of […]

When medical cannabis laws made their debut in the latter half of the 1990s, they were intended to protect cancer patients from prosecution. These patients found a medication that combatted the harsh, nauseating side effects of chemotherapy, and though cannabis’ efficacy was largely anecdotal at the time, we can now look at the science of […]

Roberto and Maria’s 13-year-old daughter has Dravet syndrome which causes many severe seizures daily. But with the help of a cannabis compound, she’s been nearly seizure free.  It’s bed time for 13-year-old Viridiana. And as her parents, Roberto and Maria, read to her, they know their daughter’s own story is different than a normal child’s. […]

Roberto and Maria’s 13-year-old daughter has Dravet syndrome which causes many severe seizures daily. But with the help of a cannabis compound, she’s been nearly seizure free.  It’s bed time for 13-year-old Viridiana. And as her parents, Roberto and Maria, read to her, they know their daughter’s own story is different than a normal child’s. […]

Leaf relief: Marijuana contains hundreds of chemicals, one of which seems to alleviate seizures. underworld111 / iStock A component of marijuana called cannabidiol eased seizures in children with Dravet syndrome, a potentially fatal form of epilepsy, in a late-stage clinical trial1. Dravet syndrome stems from mutations in sodium channels, most often in a gene called […]

Worldwide Clinical Trials is developing a pre-IND plan and designing pilot studies for evaluating the effectiveness of GB Sciences’ proprietary cannabis-based therapeutic, says CMSO. As part of the consulting services agreement, Worldwide Clinical Trials will evaluate the cannabis company’s intellectual property portfolio and will assist with pre-IND planning. Worldwide’s chief medical and scientific officer, Michael […]

PETACH TIKVA, Israel, July 25, 2017 /PRNewswire/ — OWC Pharmaceutical Research Corp. (OTCQB: OWCP), (“OWC” or the “Company”), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the appointment of Dr. Stanley Hirsch as its active chairman of the board of directors.      (Logo: http://mma.prnewswire.com/media/458036/OWC_Logo.jpg ) Dr. Stanley […]

TEL AVIV, Israel, July 24, 2017 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTC-QB: CNBX) today announced it has established a Genetic lab that will develop diagnostic tools based on human genome, tumor genetics and cannabinoids.      (Logo: http://mma.prnewswire.com/media/485543/Cannabics_Logo.jpg ) The company recruited Dr. Moran Grinberg to serve as its VP of RD and to lead the […]